Skip to main content

Table 4 Change in body weight following liraglutide does not mediate change in ceramide levels

From: Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

 

LirAlbu12

LiraFlame26

 

Total effect estimate

Total effect P-value

ACME estimate

ACME P-value

Total effect estimate

Total effect P-value

ACME estimate

ACME P-value

C16 Cer

0.025 (-0.03;0.079)

0.372

-0.004 (-0.032;0.021)

0.718

2.634*10–4 (1.954*10–5;5.004*10–4)

0.044

7.641*10–6 (-1.421*10–4;1.796*10–4)

0.908

C18 Cer

0.024 (-0.038;0.088)

0.492

0.003 (-0.028;0.034)

0.758

5.527*10–4 (-1.182*10–4;1.259*10–3)

0.102

4.530*10–5 (-3.698*10–4;4.983*10–4)

0.798

C20 Cer

0.037 (-0.053;0.141)

0.45

0.002 (-0.048;0.047)

0.912

-2.777*10–5 (-7.603*10–5;2.105*10–5)

0.314

2.285*10–5 (-1.929*10–6;5.199*10–5)

0.076

C22 Cer

0.281 (-0.21;0.775)

0.262

0.031 (-0.187;0.241)

0.724

1.432*10–4 (-1.988*10–4;4.755*10–4)

0.37

2.973*10–5 (-1.230*10–4;2.119*10–4)

0.788

C24 Cer

1.272 (-0.762;3.59)

0.238

-0.238 (-1.312;0.687)

0.716

2.703*10–2 (-9.487*10–3;6.170*10–2)

0.168

-1.562*10–3 (-2.448*10–2;1.971*10–2)

0.88

C24:1 Cer

-0.025 (-0.687;0.642)

0.958

0.074 (-0.205;0.403)

0.616

1.178*10–2 (-2.336*10–3;2.387*10–2)

0.094

-9.104*10–4 (-8.647*10–3;6.183*10–3)

0.85

  1. Mediation effect was assessed by linear regression models with and without adjustment for the tested confounder the effect and significance were estimated by bootstrapping 1000 times using the mediator package in R
  2. ACME Average casual mediation effect